Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Clinicopathologic study of E-cadherin/beta-catenin complex, and topoisomerase-II in a series of 71 liposarcoma cases.

Gogou P, Pakos E, Batistatou A, Panelos I, Briasoulis E, Stefanou D, Apostolikas N, Tsekeris P.

World J Surg Oncol. 2012 Feb 2;10:28. doi: 10.1186/1477-7819-10-28.

PMID:
22300273
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Expression of E-cadherin, beta-catenin and topoisomerase IIalpha in leiomyosarcomas.

Gogou PN, Batistatou A, Pakos EE, Apostolikas N, Stefanou D, Tsekeris PG.

Clin Transl Oncol. 2009 Aug;11(8):548-51.

PMID:
19661031
[PubMed - indexed for MEDLINE]
3.

Investigation of β-catenin and E-cadherin expression in Dukes B2 stage colorectal cancer with tissue microarray method. Is it a marker of metastatic potential in rectal cancer?

Tóth L, András C, Molnár C, Tanyi M, Csiki Z, Molnár P, Szántó J.

Pathol Oncol Res. 2012 Apr;18(2):429-37. doi: 10.1007/s12253-011-9463-y.

PMID:
21975680
[PubMed - indexed for MEDLINE]
4.

Real time PCR analyses of expression of E-cadherin, alpha-, beta- and gamma-catenin in human breast cancer for predicting clinical outcome.

Goyal A, Martin TA, Mansel RE, Jiang WG.

World J Surg Oncol. 2008 Jun 11;6:56. doi: 10.1186/1477-7819-6-56.

PMID:
18547424
[PubMed - indexed for MEDLINE]
Free PMC Article
5.
6.

Topoisomerase I and IIalpha protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy.

Tsavaris N, Lazaris A, Kosmas C, Gouveris P, Kavantzas N, Kopterides P, Papathomas T, Agrogiannis G, Zorzos H, Kyriakou V, Patsouris E.

Cancer Chemother Pharmacol. 2009 Jul;64(2):391-8. doi: 10.1007/s00280-008-0886-4. Epub 2008 Dec 16. Erratum in: Cancer Chemother Pharmacol. 2009 Jul;64(2):399. Arapogiannis, George [corrected to Agrogiannis, George]; Patsouris, Efstathios [corrected to Patsouris, Efstratios].

PMID:
19083133
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

β-Catenin and E-cadherin expression in stage I adult-type granulosa cell tumour of the ovary: correlation with tumour morphology and clinical outcome.

Stewart CJ, Doherty D, Guppy R, Louwen K, Leung YC.

Histopathology. 2013 Jan;62(2):257-66. doi: 10.1111/j.1365-2559.2012.04334.x. Epub 2012 Sep 7.

PMID:
22958082
[PubMed - indexed for MEDLINE]
8.

Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer.

Stefansson IM, Salvesen HB, Akslen LA.

J Clin Oncol. 2004 Apr 1;22(7):1242-52.

PMID:
15051772
[PubMed - indexed for MEDLINE]
9.

The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract.

Kashibuchi K, Tomita K, Schalken JA, Kume H, Yamaguchi T, Muto S, Horie S, Kitamura T.

Eur Urol. 2006 May;49(5):839-45; discussion 845. Epub 2006 Jan 6.

PMID:
16426728
[PubMed - indexed for MEDLINE]
10.

Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.

Ohene-Abuakwa Y, Noda M, Perenyi M, Kobayashi N, Kashima K, Hattori T, Pignatelli M.

J Pathol. 2000 Dec;192(4):433-9.

PMID:
11113859
[PubMed - indexed for MEDLINE]
11.

Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer.

Choi YS, Shim YM, Kim SH, Son DS, Lee HS, Kim GY, Han J, Kim J.

Eur J Cardiothorac Surg. 2003 Sep;24(3):441-9.

PMID:
12965318
[PubMed - indexed for MEDLINE]
12.

Frequent occurrence of abnormal E-cadherin/beta-catenin protein expression in advanced gallbladder cancers and its association with decreased apoptosis.

Hirata K, Ajiki T, Okazaki T, Horiuchi H, Fujita T, Kuroda Y.

Oncology. 2006;71(1-2):102-10. Epub 2007 Mar 6.

PMID:
17341890
[PubMed - indexed for MEDLINE]
13.

E-cadherin and β-catenin expression in sebaceous eyelid adenocarcinomas.

Li L, Zhang Z, Li B, Gao F, Li L, Jonas JB.

Graefes Arch Clin Exp Ophthalmol. 2011 Dec;249(12):1867-73. doi: 10.1007/s00417-011-1729-2. Epub 2011 Jul 8.

PMID:
21739269
[PubMed - indexed for MEDLINE]
14.

Expression of e-cadherin and catenins in early gastric cancer.

Joo YE, Rew JS, Choi SK, Bom HS, Park CS, Kim SJ.

J Clin Gastroenterol. 2002 Jul;35(1):35-42.

PMID:
12080224
[PubMed - indexed for MEDLINE]
15.

Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.

Stathopoulos GP, Kapranos N, Manolopoulos L, Papadimitriou C, Adamopoulos G.

Anticancer Res. 2000 Jan-Feb;20(1A):177-82.

PMID:
10769652
[PubMed - indexed for MEDLINE]
16.

An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.

Gonzalez MA, Pinder SE, Wencyk PM, Bell JA, Elston CW, Nicholson RI, Robertson JF, Blamey RW, Ellis IO.

J Pathol. 1999 Apr;187(5):523-9.

PMID:
10398116
[PubMed - indexed for MEDLINE]
17.

Combined loss of E-cadherin and aberrant β-catenin protein expression correlates with a poor prognosis for small intestinal adenocarcinomas.

Lee HJ, Lee OJ, Jang KT, Bae YK, Chung JY, Eom DW, Kim JM, Yu E, Hong SM.

Am J Clin Pathol. 2013 Feb;139(2):167-76. doi: 10.1309/AJCPS54RTFCTHGWX.

PMID:
23355201
[PubMed - indexed for MEDLINE]
Free Article
18.

E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.

Davidson B, Berner A, Nesland JM, Risberg B, Berner HS, Tropè CG, Kristensen GB, Bryne M, Ann Florenes V.

J Pathol. 2000 Dec;192(4):460-9.

PMID:
11113863
[PubMed - indexed for MEDLINE]
19.

E-cadherin, b-catenin and topoisomerase II expression in rhabdomyosarcomas.

Gogou PN, Batistatou A, Pakos EE, Apostolikas N, Stefanou D, Tsekeris PG.

J BUON. 2009 Apr-Jun;14(2):323-4. No abstract available.

PMID:
19650189
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk